Before the development of effective regimens for replacing fluids and electrolyte losses, the mortality rate in severe disease was more than 50%. 
With the development of effective intravenous and oral rehydration solutions, no patient who reaches a cholera treatment center alive should die of the disease. 
Mortality rates are lowest where intravenous therapy is available. At the Treatment Center of the International Center for Diarrheal Disease Research, Bangladesh, fewer than 1% of patients with severe dehydration die. 
Although mortality rates in Africa remain higher, low case-fatality rates also have been achieved in South America, presumably because of the availability of adequate treatment facilities and trained personne